Jasper Therapeutics (JSPR) Earnings Date & Reports
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
JSPR is expected to report earnings to rise 8.51% to -152 cents per share on March 15
Q4'23
Est.
$-1.53
Q1'25
Beat
by $0.39
Q4'24
Missed
by $0.22
Q3'23
Missed
by $1.44
Q2'23
Est.
$-0.15
The last earnings report on May 12 showed earnings per share of -140 cents, beating the estimate of -179 cents. With 316.85K shares outstanding, the current market capitalization sits at 90.28M.